General Information of the Compound
| Compound ID |
CP0065986
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2,3,4,9-Tetrahydro-1H-beta-carboline
Show/Hide
|
||||||||||||||||||
| Synonyms |
1,2,3,4-Tetrahydro-9H-pyrido[3,4-b]indole
1,2,3,4-Tetrahydro-beta-carboline
1,2,3,4-tetrahydrobeta-carboline
16502-01-5
1H,2H,3H,4H,9H-Pyrido[3,4-B]Indole
1H-Pyrido[3,4-b]indole, 2,3,4,9-tetrahydro-
2,3,4,9-tetrahydro-1H-Pyrido[3,4-b]indole
2,3,4,9-tetrahydro-1H-beta-carboline
65027TMI0H
CHEMBL269236
MLS000069483
Noreleagnine
SMR000059115
THBC
TRYPTOLINE
Tetrahydro-beta-carboline
Tetrahydro-beta-carboline, 98%
Tetrahydronorharman
Tetrahydronorharmane
Triptoline
Tryptoline
UNII-65027TMI0H
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C11H12N2
|
||||||||||||||||||
| Molecular Weight |
172.231
|
||||||||||||||||||
| Canonical SMILES |
C1Cc2c(CN1)[nH]c1ccccc21
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C11H12N2/c1-2-4-10-8(3-1)9-5-6-12-7-11(9)13-10/h1-4,12-13H,5-7H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
CFTOTSJVQRFXOF-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06109, Geminin
Protein ID: PT05586, Nuclear receptor subfamily 2 group E member 1
Clinical Information about the Compound
Drug 1 ( TRYPTOLINE )
| Drug Name | TRYPTOLINE | ||
|---|---|---|---|
| Target(s) | |||